UK Users

Access Prodigy topics and clinical content at the NICE website.

Visit the NICE website

Free Trial

To arrange a free trial of the Prodigy application, get in touch.

Contact us to arrange a trial

International Users

The Prodigy application is available on a subscription basis.

Subscription types

Sample Topic: Asthma

This is an annotation about the references section of the topic.

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Donec odio. Quisque volutpat mattis eros. Nullam malesuada erat ut turpis. Suspendisse urna nibh, viverra non, semper suscipit, posuere a, pede.

Asthma : Last revised in December 2013


References

All references with links to [Free Full-text] are freely available online to users in the UK. Links to PubMed abstracts are also provided where available. Clarity is not responsible for the content of external sites

Free Full-text links are to dynamic documents that may have been updated since they were originally cited in the Prodigy topic. All links are checked regularly by Information Specialists and updated to the latest version. Changes in the content of updated documents will not be reflected in the Prodigy topic text until the next revision.

The following references were cited in November 2008. References dated after this reflect new evidence incorporated since original publication of this topic.

  1. ABPI Medicines Compendium (2004) Summary of product characteristics for Accolate. Electronic Medicines Compendium. Datapharm Communications Ltd. www.medicines.org.uk [Free Full-text]
  2. ABPI Medicines Compendium (2007) Summary of product characteristics for Singulair paediatric 4mg granules. Electronic Medicines Compendium. Datapharm Communications Ltd. www.medicines.org.uk [Free Full-text]
  3. ABPI Medicines Compendium (2010) Summary of product characteristics for Xolair 150 mg powder and solvent for solution for injection. Electronic Medicines Compendium. Datapharm Communications Ltd. www.medicines.org.uk [Free Full-text]
  4. ABPI Medicines Compendium (2011a) Summary of product characteristics for Clenil Modulite 50, 100, 200, 250 micrograms inhaler. Electronic Medicines Compendium. Datapharm Communications Ltd. www.medicines.org.uk [Free Full-text]
  5. ABPI Medicines Compendium (2011b) Summary of product characteristics for Bricanyl Turbohaler, 0.5mg/dose, inhalation powder. Electronic Medicines Compendium. Datapharm Communications Ltd. www.medicines.org.uk [Free Full-text]
  6. Agertoft, L. and Pedersen, S. (2000) Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. New England Journal of Medicine 343(15), 1064-1069. [Abstract] [Free Full-text]
  7. American Lung Association Asthma Clinical Research Centers (2007) Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine 175(3), 235-242. [Abstract] [Free Full-text]
  8. Anderson, H.R. (2005) Prevalence of asthma. British Medical Journal 330(7499), 1037-1038. [Free Full-text]
  9. Asthma UK (2006) Where do we stand? Asthma in the UK today. Asthma UK. www.asthma.org.uk
  10. Bernard-Bonnin, A.C., Stachenko, S., Bonin, D. et al. (1995) Self-management teaching programs and morbidity of pediatric asthma: a meta-analysis. Journal of Allergy and Clinical Immunology 95(1), 34-41. [Abstract]
  11. Bhogal, S., Zemek, R. and Ducharme, F.M. (2006) Written action plans for asthma in children (Cochrane Review). The Cochrane Library. Issue 3. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  12. BMA and NHS Employers (2011) Summary of 2011/12 QOF indicator changes, points and thresholds. BMA and NHS Employers. www.nhsemployers.org [Free Full-text]
  13. BMA and NHS Employers (2012) Quality and outcomes framework for 2012/13. Guidance for PCOs and practices. BMA and NHS Employers. www.bma.org.uk [Free Full-text]
  14. BMA and NHS Employers (2013) Summary of QOF changes for 2013/14 in England. British Medical Association and NHS Employers. www.nhsemployers.org [Free Full-text]
  15. BNF 53 (2007) British National Formulary. 53rd edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain.
  16. BNF for Children (2007) British National Formulary for children. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain.
  17. Brocklebank, D., Wright, J. and Cates, C. (2001) Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma. British Medical Journal 323(7318), 896-900. [Abstract] [Free Full-text]
  18. Burr, M.L., Wat, D., Evans, C. et al. (2006) Asthma prevalence in 1973, 1988 and 2003. Thorax 61(4), 296-299. [Abstract] [Free Full-text]
  19. Busse, W.W., Casale, T.B., Dykewicz, M.S. et al. (2006) Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity. Annals of Allergy, Asthma & Immunology 96(1), 60-68. [Abstract]
  20. Castro-Rodriguez, J.A. and Rodrigo, G.J. (2004) beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. Journal of Pediatrics 145(2), 172-177. [Abstract]
  21. Cates, C.J. and Lasserson, T.J. (2009) Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children (Cochrane Review). The Cochrane Library. Issue 2. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  22. Cates, C.J., Jefferson, T.O., Bara, A.I. and Rowe, B.H. (2003) Vaccines for preventing influenza in people with asthma (Cochrane Review). The Cochrane Library. Issue 4. John Wiley & Sons, Ltd. www.thecochranelibrary.com
  23. Childhood Asthma Management Program Research Group (2000) Long-term effects of budesonide or nedocromil in children with asthma. New England Journal of Medicine 343(15), 1054-1063. [Abstract] [Free Full-text]
  24. CHM (2006) High dose of inhaled steroids: new advice on supply of steroid treatment cards. Current Problems in Pharmacovigilance 31(May), 5. [Free Full-text]
  25. Cooper, S., Oborne, J., Newton, S. et al. (2003) Effect of two breathing exercise (Buteyko and pranayama) in asthma: a randomised controlled trial. Thorax 58(8), 674-679. [Abstract] [Free Full-text]
  26. Cote, J., Bowie, D.M., Robichaud, P. et al. (2001) Evaluation of two different educational interventions for adult patients consulting with an acute asthma exacerbation. American Journal of Respiratory and Critical Care Medicine 163(6), 1415-1419. [Abstract] [Free Full-text]
  27. CSM (1990) Beta-agonists, xanthines and hypokalaemia. Current Problems in Pharmacovigilance 28(May), 3. [Free Full-text]
  28. CSM (1998) Focus on corticosteroids. Current Problems in Pharmacovigilance 24(May), 5-10. [Free Full-text]
  29. CSM (2001) Reminder: fluticasone propionate (Flixotide): use of high doses (>500 micrograms/twice daily). Current Problems in Pharmacovigilance 27(Aug), 10. [Free Full-text]
  30. CSM (2002) Inhaled corticosteroids and adrenal suppression in children. Current Problems in Pharmacovigilance 28(Oct), 7. [Free Full-text]
  31. Currie, G.P., Devereux, G.S., Lee, D.K. and Ayres, J.G. (2005) Recent developments in asthma management. British Medical Journal 330(7491), 585-589. [Free Full-text]
  32. de Marco, R., Locatelli, F., Sunyer, J. and Burney, P. (2000) Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey. American Journal of Respiratory and Critical Care Medicine 162(1), 68-74. [Abstract] [Free Full-text]
  33. Demissie, K., Breckenridge, M.B. and Rhoads, G.G. (1998) Infant and maternal outcomes in the pregnancies of asthmatic women. American Journal of Respiratory and Critical Care Medicine 158(4), 1091-1095. [Abstract] [Free Full-text]
  34. DH (2006a) Immunisation against infectious disease – “The Green Book”. Chapter 2 – Consent. Department of Health. www.dh.gov.uk [Free Full-text]
  35. DH (2006b) Immunisation against infectious disease – “The Green Book”. Chapter 25 – Pneumococcal. Department of Health. www.dh.gov.uk [Free Full-text]
  36. Dolovich, M.B., Ahrens, R.C., Hess, D.R. et al. (2005) Device selection and outcomes of aerosol therapy: evidence-based guidelines. Chest 127(1), 335-371. [Abstract] [Free Full-text]
  37. Dombrowski, M.P., Schatz, M., Wise, R. et al. (2004) Asthma during pregnancy. Obstetrics and Gynecology 103(1), 5-12. [Abstract]
  38. Doull, I.J. (2004) The effect of asthma and its treatment on growth. Archives of Disease in Childhood 89(1), 60-63. [Abstract] [Free Full-text]
  39. DTB (2000) Inhaler devices for asthma. Drug & Therapeutics Bulletin 38(2), 9-14. [Abstract]
  40. DTB (2005) Action plans in asthma. Drug & Therapeutics Bulletin 43(12), 91-94. [Abstract]
  41. Ducharme, F.M. (2003) Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence. British Medical Journal 326(7390), 621. [Abstract] [Free Full-text]
  42. Ducharme, F., Schwartz, Z. and Kakuma, R. (2004) Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma (Cochrane Review). The Cochrane Library. Issue 1. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  43. Ducharme, F.M., Lasserson, T.J. and Cates, C.J. (2006) Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma (Cochrane Review). The Cochrane Library. Issue 4. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  44. DVLA (2010) At a glance guide to the current medical standards of fitness to drive (August update). Driver and Vehicle Licensing Agency. www.gov.uk [Free Full-text]
  45. DVLA (2011) At a glance guide to the current medical standards of fitness to drive (February 2011). Driver and Vehicle Licensing Agency. www.gov.uk [Free Full-text]
  46. EBM (1999) High-dose inhaled corticosteroids increase the risk for some systemic adverse effects in asthma. Evidence-Based Medicine 4(6), 191.
  47. Gallefoss, F. and Bakke, P.S. (2000) Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine 94(3), 279-287. [Abstract]
  48. Garcia Garcia, M.L., Wahn, U., Gilles, L. et al. (2005) Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC Study. Pediatrics 116(2), 360-369. [Abstract] [Free Full-text]
  49. Gibson, P.G. and Powell, H. (2004) Written action plans for asthma: an evidence-based review of the key components. Thorax 59(2), 94-99. [Abstract] [Free Full-text]
  50. Gibson, P.G., Powell, H. and Ducharme, F. (2005) Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children (Cochrane Review). The Cochrane Library. Issue 4. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  51. GINA (2006) Global strategy for asthma management and prevention. Global Initiative for Asthma.
  52. Giraud, V. and Roche, N. (2002) Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. European Respiratory Journal 19(2), 246-251. [Abstract] [Free Full-text]
  53. Gluck, J.C. and Gluck, P.A. (2005) Asthma controller therapy during pregnancy. American Journal of Obstetrics and Gynecology 192(2), 369-380. [Abstract]
  54. Green, R.M., Custovic, A., Sanderson, G. et al. (2002) Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. British Medical Journal 324(7340), 763. [Abstract] [Free Full-text]
  55. Greenstone, I.R., Ni Chroinin, M.N., Masse, V. et al. (2005) Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma (Cochrane Review). The Cochrane Library. Issue 4. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  56. Guevara, J.P., Wolf, F.M., Grum, C.M. and Clark, N.M. (2003) Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta-analysis. British Medical Journal 326(7402), 1308-1309. [Abstract] [Free Full-text]
  57. Guevara, J.P., Ducharme, F.M., Keren, R. et al. (2006) Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma (Cochrane Review). The Cochrane Library. Issue 2. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  58. Haby, M.M., Waters, E., Robertson, C.F. et al. (2001) Interventions for educating children who have attended the emergency room for asthma (Cochrane Review). The Cochrane Library. Issue 1. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  59. Hakala, K., Stenius-Aarniala, B. and Sovijarvi, A. (2000) Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 118(5), 1315-1321. [Abstract] [Free Full-text]
  60. Harmanci, K., Bakirtas, A., Turktas, I. and Degim, T. (2006) Oral montelukast treatment of preschool-aged children with acute asthma. Annals of Allergy, Asthma and Immunology 96(5), 731-735. [Abstract]
  61. Harrison, T.W., Oborne, J., Newton, S. and Tattersfield, A.E. (2004) Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 363(9405), 271-275. [Abstract]
  62. Hermansen, M.N., Nielsen, K.G., Buchvald, F. et al. (2006) Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma. Chest 129(5), 1203-1209. [Abstract] [Free Full-text]
  63. Holloway, E.A. and West, R. (2007) Integrated breathing and relaxation training (the Papworth Method) for adults with asthma in primary care: a randomised controlled trial. Thorax 62(12), 1039-1042. [Abstract] [Free Full-text]
  64. Horak, E., Lanigan, A., Roberts, M. et al. (2003) Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42. British Medical Journal 326(7386), 422-423. [Free Full-text]
  65. Karpel, J.P., Aldrich, T.K., Prezant, D.J. et al. (1997) Emergency treatment of acute asthma with albuterol metered-dose inhaler plus holding chamber: how often should treatments be administered? Chest 112(2), 348-356. [Abstract] [Free Full-text]
  66. Keahey, L., Bulloch, B., Becker, A.B. et al. (2002) Initial oxygen saturation as a predictor of admission in children presenting to the emergency department with acute asthma. Annals of Emergency Medicine 40(3), 300-307. [Abstract]
  67. Keeley, D. and McKean, M. (2006) Asthma and other wheezing disorders in children. Clinical Evidence. BMJ Publishing Group Ltd. www.clinicalevidence.com
  68. Kelly, K., Spooner, C.H. and Rowe, B.H. (2000) Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction in asthmatics (Cochrane Review). The Cochrane Library. Issue 3. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  69. Kelly, A., Tang, R., Becker, S. and Stanley, C.A. (2008) Poor specificity of low growth hormone and cortisol levels during fasting hypoglycemia for the diagnoses of growth hormone deficiency and adrenal insufficiency. Pediatrics 122(3), e522-e528. [Abstract] [Free Full-text]
  70. Knorr, B., Franchi, L.M., Bisgaard, H. et al. (2001) Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 108(3), E48. [Abstract] [Free Full-text]
  71. Lai, C.K., Beasley, R., Crane, J. et al. (2009) Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study fo Asthma and Allergies in Childhood (ISAAC). Thorax 64(6), 476-483. [Abstract]
  72. Lasserson, T.J., Cates, C.J., Jones, A.B. et al. (2006) Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children (Cochrane Review). The Cochrane Library. Issue 2. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  73. McCormick, A., Fleming, D. and Charlton, J. (1995) Morbidity statistics from general practice. Fourth national study 1991-1992. Office of Population Censuses and Surveys. www.statistics.gov.uk
  74. MeReC (2002) Chronic asthma. MeReC Briefing 18(Jun), 1-5. [Free Full-text]
  75. MHRA (2005) Reminder: Salmeterol (Serevent) and formoterol (Oxis, Foradil) in asthma management. Medicines and Healthcare Products Regulatory Agency. www.mhra.gov.uk [Free Full-text]
  76. MHRA (2006a) Beclometasone dipropionate pressurised metered dose inhaler. Important information. Medicines and Healthcare Products Regulatory Agency. www.mhra.gov.uk
  77. MHRA (2006b) Reintroduction of the volumatic spacer device: important new information. Medicines and Healthcare Products Regulatory Agency. www.mhra.gov.uk
  78. MHRA (2007) Short-acting beta agonists: myocardial ischaemia. Drug Safety Update 1(5), 10. [Free Full-text]
  79. MHRA (2008) Long-acting beta2 agonists for asthma: review. Drug Safety Update 1(6), 9. [Free Full-text]
  80. MHRA (2010) Long-acting ╬▓2-agonists: reminder for use in children and adults. Drug Safety Update 4(2), H2. [Free Full-text]
  81. Molimard, M., Raherison, C., Lignot, S. et al. (2003) Assessment of handling or inhaler devices in real life: an observational study in 3811 patients in primary care. Journal of Aerosol Medicine 16(3), 249-254. [Abstract]
  82. Mortimer, K., Tata, L.J., Smith, C.J.P. et al. (2006) Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study. Thorax 61(5), 405-408. [Abstract] [Free Full-text]
  83. Moudgil, H., Marshall, T. and Honeybourne, D. (2000) Asthma education and quality of life in the community: a randomised controlled study to evaluate the impact on white European and Indian subcontinent ethnic groups from socioeconomically deprived areas in Birmingham, UK. Thorax 55(3), 177-183. [Abstract] [Free Full-text]
  84. Murphy, V.E., Clifton, V.L. and Gibson, P.G. (2006) Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 61(2), 169-176. [Abstract] [Free Full-text]
  85. Nathan, J.A., Pearce, L., Field, C. et al. (2006) A randomized controlled trial of follow-up of patients discharged from the hospital following acute asthma: best performed by specialist nurse or doctor? Chest 130(1), 51-57. [Abstract] [Free Full-text]
  86. Nelson, J., Strauss, L., Skowronski, M. et al. (1998) Effect of long-term salmeterol treatment on exercise-induced asthma. New England Journal of Medicine 339(3), 141-145. [Abstract] [Free Full-text]
  87. Nelson, H.S., Weiss, S.T., Bleecker, E.R. et al. (2006) The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129(1), 15-26. [Abstract] [Free Full-text]
  88. Nelson, K.A., Smith, S.R., Trinkaus, K. and Jaffe, D.M. (2008) Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years. Pediatric Emergency Care 24(1), 21-27. [Abstract]
  89. Newman Taylor, A.J. (2003) Asthma. In: Warrell, D.A., Cox, T.M., Firth, J.D. and Benz, E.J. (Eds.) Oxford textbook of medicine. 4th edn. Oxford: Oxford University Press.
  90. NICE (2000) Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma (NICE technology appraisal 10). National Institute for Health and Clinical Excellence. www.nice.org.uk [Free Full-text]
  91. NICE (2002) Inhaler devices for routine treatment of chronic asthma in older children (aged 5 – 15 years) (NICE technology appraisal 38). National Institute for Health and Clinical Excellence. www.nice.org.uk [Free Full-text]
  92. NICE (2008) Inhaled corticosteroids for the treatment of chronic asthma in adults and in children ages 12 years and over (NICE technology appraisal 138). National Institute for Health and Clinical Excellence. www.nice.org.uk [Free Full-text]
  93. NICE (2013) Key therapeutic topics – medicines management options for local implementation. National Institute for Health and Clinical Excellence. www.nice.org.uk [Free Full-text]
  94. Ni Chroinin, M., Greenstone, I.R., Danish, A. et al. (2005) Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma (Cochrane Review). The Cochrane Library. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  95. Nicolai, T., Pereszlenyiova-Bliznakova, L., Illi, S. et al. (2003) Longitudinal follow-up of the changing gender ratio in asthma from childhood to adulthood: role of delayed manifestation in girls. Pediatric Allergy and Immunology 14(4), 280-283. [Abstract]
  96. NPC (2011) Key therapeutic topics 2010/11 – Medicines management options for local implementation. National Prescribing Centre. www.npc.nhs.uk [Free Full-text]
  97. NPC (2012) Key therapeutic topics – medicines management options for local implementation. National Prescribing Centre. www.npc.nhs.uk [Free Full-text]
  98. O’Byrne, P.M., Barnes, P.J., Rodriguez-Roisin, R. et al. (2001) Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. American Journal of Respiratory and Critical Care Medicine 164(8 Pt 1), 1392-1397. [Abstract] [Free Full-text]
  99. Opolski, M. and Wilson, I. (2005) Asthma and depression: a pragmatic review of the literature and recommendations for future research. Clinical Practice and Epidemiology in Mental Health 1(Sep), 18. [Abstract] [Free Full-text]
  100. Pearlman, D.S., van Adelsberg, J., Philip, G. et al. (2006) Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Annals of Allergy, Asthma and Immunology 97(1), 98-104. [Abstract]
  101. Pearson, M.G. and Bucknall, C.E. (Eds.) (1999) Measuring clinical outcome in asthma. London: The Royal College of Physicians.
  102. Perlow, J.H., Montgomery, D., Morgan, M.A. et al. (1992) Severity of asthma and perinatal outcome. American Journal of Obstetrics and Gynecology 167(4 Pt 1), 963-967. [Abstract]
  103. Phelan, P.D., Robertson, C.F. and Olinsky, A. (2002) The Melbourne Asthma Study: 1964-1999. Journal of Allergy and Clinical Immunology 109(2), 189-194. [Abstract]
  104. Pinnock, H. and Shah, R. (2007) Asthma. BMJ Masterclass for GPs. British Medical Journal 334(7598), 847-850. [Free Full-text]
  105. Rachelefsky, G. (2003) Treating exacerbations of asthma in children: the role of systemic corticosteroids. Pediatrics 112(2), 382-397. [Abstract] [Free Full-text]
  106. Rahimi, R., Nikfar, S. and Abdollahi, M. (2006) Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: a systematic meta-analysis review. Human & Experimental Toxicology 25(8), 447-52. [Abstract]
  107. Ram, F.S., Wright, J., Brocklebank, D. and White, J.E. (2001) Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta2 agonists bronchodilators in asthma. British Medical Journal 323(7318), 901-905. [Abstract] [Free Full-text]
  108. Ram, F.S.F., Robinson, S.M., Black, P.N. and Picot, J. (2005) Physical training for asthma (Cochrane Review). The Cochrane Library. Issue 4. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  109. Rees, J. (2006) Asthma control in adults. British Medical Journal 332(7544), 767-771. [Free Full-text]
  110. Robertson, C.F. (2002) Long-term outcome of childhood asthma. Medical Journal of Australia 177(Suppl), S42-S44. [Abstract]
  111. Robertson, C.F., Price, D., Henry, R. et al. (2007) Short-course montelukast for intermittent asthma in children: a randomized controlled trial. American Journal of Respirtory and Critical Care 175(4), 323-329. [Abstract] [Free Full-text]
  112. Rodolfo, J.D., Solarte, I. and Fitzgerald, J.M. (2005) Asthma. Clinical Evidence. BMJ Publishing Group Ltd. www.clinicalevidence.com
  113. Rowe, B.H., Spooner, C., Ducharme, F.M. et al. (2001) Early emergency department treatment of acute asthma with systemic corticosteroids (Cochrane Review). The Cochrane Library. Issue 1. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  114. RPSGB (2006) Practice guidance on the care of people with asthma and chronic pulmonary disease [Withdrawn]. Royal Pharmaceutical Society of Great Britain. www.rpharms.com
  115. Salpeter, S.R., Buckley, N.S., Ormiston, T.M. and Salpeter, E.E. (2006) Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Annals of Internal Medicine 144(12), 904-912. [Abstract] [Free Full-text]
  116. Schaefer, C., Peters, P. and Miller, R.K. (Eds.) (2007) Drugs during pregnancy and lactation: treatment options and risk assessment. 2nd edn. Oxford: Academic Press.
  117. Schatz, M., Harden, K., Forsythe, A. et al. (1988) The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. Journal of Allergy and Clinical Immunology 81(3), 509-517. [Abstract]
  118. Schatz, M., Zeiger, R.S. and Hoffman, C.P. (1990) Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women. Kaiser-Permanente Asthma and Pregnancy Study Group. Chest 98(2), 389-392. [Abstract] [Free Full-text]
  119. Schatz, M., Zeiger, R.S., Hoffman, C.P. et al. (1995) Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis. American Journal of Respiratory and Critical Care Medicine 151(4), 1170-1174. [Abstract]
  120. Schuh, S., Dick, P.T., Stephens, D. et al. (2006) High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. Pediatrics 118(2), 644-650. [Abstract] [Free Full-text]
  121. Seddon, P., Bara, A., Ducharme, F.M. and Lasserson, T.J. (2006) Oral xanthines as maintenance treatment for asthma in children (Cochrane Review). The Cochrane Library. Issue 1. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  122. Sheikh, A., Alves, B. and Dhami, S. (2002) Pneumococcal vaccine for asthma (Cochrane Review). The Cochrane Library. Issue 1. John Wiley & Sons Ltd. www.thecochranelibrary.com [Free Full-text]
  123. SIGN and BTS (2005) 2005 update to the British guideline on the management of asthma [Withdrawn]. Scottish Intercollegiate Guidelines Network and British Thoracic Society. www.sign.ac.uk
  124. SIGN and BTS (2008a) British guideline on the management of asthma: a national clinical guideline. Scottish Intercollegiate Guidelines Network and British Thoracic Society. www.sign.ac.uk [Free Full-text]
  125. SIGN and BTS (2008b) British guideline on the management of asthma: a national clinical guideline (revised 2009). Scottish Intercollegiate Guidelines Network and The British Thoracic Society. www.sign.ac.uk [Free Full-text]
  126. SIGN and BTS (2011) British guideline on the management of asthma: a national clinical guideline (revised 2011). Scottish Intercollegiate Guidelines Network and The British Thoracic Society. www.sign.ac.uk [Free Full-text]
  127. Spooner, C.H., Saunders, L.D. and Rowe, B.H. (2002) Nedocromil sodium for preventing exercise-induced bronchoconstriction (Cochrane Review). The Cochrane Library. Issue 1. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  128. Sridhar, A.V. and McKean, M. (2006) Nedocromil sodium for chronic asthma in children (Cochrane Review). The Cochrane Library. Issue 3. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  129. Stenius-Aarniala, B., Poussa, T., Kvarnstrom, J. et al. (2000) Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. British Medical Journal 320(7238), 827-832. [Abstract] [Free Full-text]
  130. Tasche, M.J., Uijen, J.H., Bernsen, R.M. et al. (2000) Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review. Thorax 55(11), 913-920. [Abstract] [Free Full-text]
  131. Tata, L.J., Lewis, S.A., McKeever, T.M. et al. (2008) Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study. Thorax 63(11), 981-987. [Abstract]
  132. Tee, A.K.H., Koh, M.S., Gibson, P.G. et al. (2007) Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma (Cochrane Review). The Cochrane Library. Issue 3. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  133. Thomson, N.C., Chaudhuri, R. and Livingston, E. (2004) Asthma and cigarette smoking. European Respiratory Journal 24(5), 822-833. [Abstract] [Free Full-text]
  134. Tomlinson, J.E.M., McMahon, A.D., Chaudhuri, R. et al. (2005) Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 60(4), 282-287. [Abstract] [Free Full-text]
  135. UKMI (2002) Monitoring drug therapy. North West Drug Information Letter. No. 120. UK Medicines Information. www.ukmi.nhs.uk [Free Full-text]
  136. Vuillermin, P., South, M. and Robertson, C. (2006) Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children (Cochrane Review). The Cochrane Library. Issue 3. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  137. Walters, E.H., Gibson, P.G., Lasserson, T.J. and Walters, J.A.E. (2007) Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid (Cochrane Review). The Cochrane Library. Issue 1. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  138. Warner, J. (2006) Personal communication. Consultant in Paediatrics, Imperial College, St Mary’s Hospital: London.
  139. Wolf, F.M., Guevara, J.P., Grum, C.M. et al. (2002) Educational interventions for asthma in children (Cochrane Review). The Cochrane Library. Issue 4. John Wiley & Sons Ltd. www.thecochranelibrary.com [Free Full-text]
  140. Wolthers, O.D. (2002) Growth problems in children with asthma. Hormone Research 57(Suppl 2), 83-87. [Abstract]
  141. Woodcock, A., Forster, L., Matthews, E. et al. (2003) Control of exposure to mite allergen and allergen impermeable bed covers for adults with asthma. New England Journal of Medicine 349(3), 225-236. [Abstract] [Free Full-text]